The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
View ORCID ProfileAidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
doi: https://doi.org/10.1101/2020.11.23.20237206
Aidan M. Nikiforuk
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
MSc.Kevin S. Kuchinski
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
BSc.David D.W. Twa
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
3British Columbia Cancer Research Centre, Vancouver, V5Z 1L3, British Columbia, Canada
PhDChristine D. Lukac
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
MPHHind Sbihi
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
PhDC. Andrew Basham
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
MSc.Christian Steidl
3British Columbia Cancer Research Centre, Vancouver, V5Z 1L3, British Columbia, Canada
MDNatalie A. Prystajecky
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
PhDAgatha N. Jassem
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
PhDMel Krajden
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
MDDavid M Patrick
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
MDInna Sekirov
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data that support the findings of this study are available from the data steward but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the data steward.
Posted November 27, 2020.
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
Aidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
medRxiv 2020.11.23.20237206; doi: https://doi.org/10.1101/2020.11.23.20237206
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
Aidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
medRxiv 2020.11.23.20237206; doi: https://doi.org/10.1101/2020.11.23.20237206
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4029)
- Geriatric Medicine (379)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (359)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (563)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6469)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)